Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Computerized Attention Functions Training Vs. Executive Functions Training for Children with ADHD [NA]
A completed clinical trial comparing computerized attention functions training to executive functions training in children with Attention-De…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: An Internet-delivered Intervention for Parents of Children With ADHD [NA]
A completed clinical trial evaluating an Internet-delivered intervention for parents of children with ADHD.
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Genetic, Brain Structure, and Environmental Effects on ADHD
A completed study examining how genetic factors, brain structure, and environmental influences affect attention-deficit/hyperactivity disord…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Evaluation of Immediate-Release Viloxazine in Adults With ADHD [Phase 1, Phase 2]
Phase 1/2 trials evaluating immediate-release viloxazine in adults with ADHD have completed, and results were posted in October 2024.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: The Effectiveness of Cognitive-Functional Remote Group Intervention (Cog-Fun RG) for Adults with Attention Deficit Hyperactivity Disorder (ADHD) [NA]
This clinical trial update describes the ongoing study evaluating Cog-Fun RG, a remote cognitive-functional group intervention, for adults w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Encouraging Positive Parenting Habits [NA]
Sponsored by D'Or Institute for Research and Education, this clinical trial is recruiting to evaluate whether encouraging positive parenting…
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: Effects of HIIT VR Exergame on Attention and Executive Function in Young People With ADHD [NA]
A clinical trial evaluating the effects of a high-intensity interval training (HIIT) VR exergame on attention and executive function in youn…
-
FDA approval · 2024-10-07FDA Approved: METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for methylphenidate hydrochloride extended-release (SpecGx LLC). This action represents the approval…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Effect of ASI on Sensory, Motor, Cognitive, Behavioral Skills and Social Participation in Children With ADHD [NA]
A completed study evaluating Ayres Sensory Integration therapy on sensory, motor, cognitive, behavioral skills and social participation in c…
-
FDA approval · 2024-10-01FDA Approved: METHYLPHENIDATE HYDROCHLORIDE (LA) — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva's long-acting methylphenidate hydrochloride product. This action confirms regulatory author…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder [Phase 3]
Phase 3 trial results report long-term safety and tolerability of centanafadine sustained-release tablets in adults with ADHD.
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: A Trial of Centanafadine Efficacy and Safety in Adolescents With Attention- Deficit/Hyperactivity Disorder [Phase 3]
The document reports that a Phase 3 trial evaluating centanafadine for adolescents with attention-deficit/hyperactivity disorder has complet…
-
FDA approval · 2024-09-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (SpecGx LLC)
The FDA approved a supplemental application for lisdexamfetamine dimesylate (generic) submitted by SpecGx LLC under ANDA 211840.
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: A Comparison of Group Cognitive Behavioural Therapy (CBT) and Structured Activity Group for Adults With Attention Deficit Hyperactivity Disorder (ADHD) [NA]
The document reports on a clinical trial comparing group cognitive behavioural therapy to a structured activity group for adults with Attent…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Guided ADHD Therapy for Managing the Extent and Severity of Symptoms [NA]
This clinical trial update reports the completed study of a guided therapy approach for managing the extent and severity of ADHD symptoms. N…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: ACT for Parents of Children With Neurodevelopmental Comorbidities [NA]
Completed clinical trial update on Acceptance and Commitment Therapy (ACT) for parents of children with neurodevelopmental comorbidities, in…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study of the Efficacy of Sulforaphane in Children Aged 6 to 12 With Attention Deficit Disorder With or Without Hyperactivity [NA]
A clinical trial evaluating sulforaphane for attention deficit hyperactivity disorder in children aged 6 to 12; the study status is not yet …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Dialectical Behavioral Therapy Skills for Impulsive Aggression [NA]
A clinical trial evaluating dialectical behavior therapy skills for impulsive aggression in individuals with ADHD has completed.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Effectiveness and Security Testing of a Mobile App [NA]
A clinical trial protocol for evaluating the effectiveness and security of a mobile app in Attention-Deficit/Hyperactivity Disorder, current…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: FAB Programme for Parents of Children With NDD [NA]
The Chinese University of Hong Kong is recruiting for the FAB Programme trial in parents of children with neurodevelopmental disorders, incl…
-
FDA approval · 2024-09-16FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's supplemental application to market lisdexamfetamine dimesylate as a generic drug, expanding access…
-
FDA approval · 2024-09-16FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
The FDA approved a supplemental application for lisdexamfetamine dimesylate from Teva Pharmaceuticals under an ANDA, approving changes to th…
-
FDA approval · 2024-09-10FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (KVK-TECH, INC)
FDA approved a supplemental application for Dexmethylphenidate hydrochloride from KVK-Tech, Inc., granting approval of a generic product und…
-
FDA approval · 2024-09-10FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
FDA approved a supplemental application for a generic Dexmethylphenidate hydrochloride product from Nivagen Pharmaceuticals, expanding acces…
-
FDA approval · 2024-09-09FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
The FDA approved Lupin Pharmaceuticals, Inc.'s supplemental application for dexmethylphenidate hydrochloride, signaling approval of a generi…